Chronic Lymphocytic LeukemiaCancer
What this study is
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Study details
- Sponsor
- Dana-Farber Cancer Institute
- Conditions
- Chronic Lymphocytic Leukemia
- Enrolling
- 2,750 people
- Starts
- 1999-09-29
- Est. completion
- 2032-09-29
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- Any low grade lymphoproliferative disorder
- Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openDana Farber Cancer Institute
Boston, Massachusetts, United States
- Jennifer Brown, MD, PhD · Contact617-582-8437Jennifer_brown@dfci.harvard.edu
- Jennifer Brown, MD, PhD · Principal investigator
Recruiting
Study team
Sponsor
Dana-Farber Cancer Institute
Study ID 99-224
Principal investigator
Jennifer Brown, MD,PhD
Dana-Farber Cancer Institute
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.